학술논문
A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug–Drug Interaction Frequently Observed in Graft versus Host Disease Patients
Document Type
Article
Author
Source
In: Pharmaceutics . (Pharmaceutics, December 2022, 14(12))
Subject
Language
English
ISSN
19994923